Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adrenergic signaling in cardiomyocytes 💬
1件: AGTR1 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
2 Adrenergic signaling in cardiomyocytes 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
3 AGE-RAGE signaling pathway in diabetic complications 💬
1件: AGTR1 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
4 AGE-RAGE signaling pathway in diabetic complications 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
5 Aldosterone synthesis and secretion 💬
1件: AGTR1 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
6 Aldosterone synthesis and secretion 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
7 Aldosterone-regulated sodium reabsorption 💬
1件: NR3C2 💬 D00443 💬 Spironolactone 7件: 58, 67, 86, 113, 210, 218, 225 💬
8 AMPK signaling pathway 💬
1件: HMGCR 💬 D00892 💬 Fluvastatin 3件: 79, 218, 222 💬
9 AMPK signaling pathway 💬
1件: HMGCR 💬 D07983 💬 Fluvastatin 3件: 79, 218, 222 💬
10 Apelin signaling pathway 💬
1件: AGTR1 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
11 Apelin signaling pathway 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
12 Bile secretion 💬
1件: HMGCR 💬 D00892 💬 Fluvastatin 3件: 79, 218, 222 💬
13 Bile secretion 💬
1件: HMGCR 💬 D07983 💬 Fluvastatin 3件: 79, 218, 222 💬
14 Calcium signaling pathway 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
15 Calcium signaling pathway 💬
2件: AGTR1, EDNRA 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
16 cAMP signaling pathway 💬
1件: EDNRA 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
17 cGMP-PKG signaling pathway 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
18 cGMP-PKG signaling pathway 💬
2件: AGTR1, EDNRA 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
19 Chagas disease 💬
1件: ACE 💬 D00620 💬 Benazepril 4件: 49, 57, 218, 224 💬
20 Chagas disease 💬
1件: ACE 💬 D07499 💬 Benazepril 4件: 49, 57, 218, 224 💬
21 Chagas disease 💬
1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
22 Chemical carcinogenesis - receptor activation 💬
1件: VDR 💬 D00930 💬 Paricalcitol 4件: 19, 66, 218, 238 💬
23 Coronavirus disease - COVID-19 💬
1件: ACE 💬 D00620 💬 Benazepril 4件: 49, 57, 218, 224 💬
24 Coronavirus disease - COVID-19 💬
1件: ACE 💬 D07499 💬 Benazepril 4件: 49, 57, 218, 224 💬
25 Coronavirus disease - COVID-19 💬
1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
26 Coronavirus disease - COVID-19 💬
1件: AGTR1 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
27 Coronavirus disease - COVID-19 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
28 Cortisol synthesis and secretion 💬
1件: AGTR1 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
29 Cortisol synthesis and secretion 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
30 Cushing syndrome 💬
1件: AGTR1 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
31 Cushing syndrome 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
32 Diabetic cardiomyopathy 💬
1件: ACE 💬 D00620 💬 Benazepril 4件: 49, 57, 218, 224 💬
33 Diabetic cardiomyopathy 💬
1件: ACE 💬 D07499 💬 Benazepril 4件: 49, 57, 218, 224 💬
34 Diabetic cardiomyopathy 💬
1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
35 Diabetic cardiomyopathy 💬
1件: AGTR1 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
36 Diabetic cardiomyopathy 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
37 Endocrine and other factor-regulated calcium reabsorption 💬
1件: VDR 💬 D00930 💬 Paricalcitol 4件: 19, 66, 218, 238 💬
38 Hypertrophic cardiomyopathy 💬
1件: ACE 💬 D00620 💬 Benazepril 4件: 49, 57, 218, 224 💬
39 Hypertrophic cardiomyopathy 💬
1件: ACE 💬 D07499 💬 Benazepril 4件: 49, 57, 218, 224 💬
40 Hypertrophic cardiomyopathy 💬
1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
41 Metabolic pathways 💬
1件: HMGCR 💬 D00892 💬 Fluvastatin 3件: 79, 218, 222 💬
42 Metabolic pathways 💬
1件: HMGCR 💬 D07983 💬 Fluvastatin 3件: 79, 218, 222 💬
43 Mineral absorption 💬
1件: VDR 💬 D00930 💬 Paricalcitol 4件: 19, 66, 218, 238 💬
44 Neuroactive ligand-receptor interaction 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
45 Neuroactive ligand-receptor interaction 💬
2件: AGTR1, EDNRA 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
46 Parathyroid hormone synthesis, secretion and action 💬
1件: VDR 💬 D00930 💬 Paricalcitol 4件: 19, 66, 218, 238 💬
47 Pathways in cancer 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
48 Pathways in cancer 💬
2件: AGTR1, EDNRA 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
49 Phospholipase D signaling pathway 💬
1件: AGTR1 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
50 Phospholipase D signaling pathway 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
51 Renin secretion 💬
1件: ACE 💬 D00620 💬 Benazepril 4件: 49, 57, 218, 224 💬
52 Renin secretion 💬
1件: ACE 💬 D07499 💬 Benazepril 4件: 49, 57, 218, 224 💬
53 Renin secretion 💬
1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
54 Renin secretion 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
55 Renin secretion 💬
2件: AGTR1, EDNRA 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
56 Renin-angiotensin system 💬
1件: ACE 💬 D00620 💬 Benazepril 4件: 49, 57, 218, 224 💬
57 Renin-angiotensin system 💬
1件: ACE 💬 D07499 💬 Benazepril 4件: 49, 57, 218, 224 💬
58 Renin-angiotensin system 💬
1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
59 Renin-angiotensin system 💬
1件: AGTR1 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬
60 Renin-angiotensin system 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
61 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 D00892 💬 Fluvastatin 3件: 79, 218, 222 💬
62 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 D07983 💬 Fluvastatin 3件: 79, 218, 222 💬
63 Tuberculosis 💬
1件: VDR 💬 D00930 💬 Paricalcitol 4件: 19, 66, 218, 238 💬
64 Vascular smooth muscle contraction 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
65 Vascular smooth muscle contraction 💬
2件: AGTR1, EDNRA 💬 D11776 💬 Sparsentan 3件: 66, 218, 222 💬